Beta Drugs Ltd BETA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 2:59 PM IST
924.00quote price arrow up+13.55 (+1.49%)
Volume
5,200
52 week range
251.10 - 1,024.40
Loading...
  • Open911.25
  • Day High943.75
  • Day Low911.00
  • Prev Close910.45
  • 52 Week High1,024.40
  • 52 Week High Date05/02/22
  • 52 Week Low251.10
  • 52 Week Low Date05/17/21

Key Stats

  • Market Cap112.65M
  • Shares Out9.61M
  • 10 Day Average Volume9,490.91
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change46.32

KEY STATS

  • Open911.25
  • Day High943.75
  • Day Low911.00
  • Prev Close910.45
  • 52 Week High1,024.40
  • 52 Week High Date05/02/22
  • 52 Week Low251.10
  • 52 Week Low Date05/17/21
  • Market Cap112.65M
  • Shares Out9.61M
  • 10 Day Average Volume9,490.91
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change46.32

RATIOS/PROFITABILITY

  • EPS (TTM)5.99
  • P/E (TTM)154.31
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Beta Drugs Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Beta Drugs Limited is an India-based company that is engaged in the business of manufacturing of oncology medicines. The Company offers a range of oncology products including tablets, capsules and injections. The Company offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, brain, bone, lung, mouth, head and neck, prostate, leukemia, lymphoma and supportive cancer and others. The Company’s oncology portfolio...
Vijay Batra
Chairman of the Board, Managing Director
Jayant Kumar
Chief Financial Officer
Address
Sco 184, Sector 5, Panchkula
Panchkula
134114
India